Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Kearns

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Allergy and Clinical Immunology|September 13, 2000
Impact of developmental pharmacology on pediatric study design: overcoming the challengesG L Kearns
The Annals of Pharmacotherapy|January 1, 1993
Hepatic drug metabolism in cystic fibrosis: recent developments and future directionsG L Kearns
Clinical Pharmacology and Therapeutics|June 16, 2015
Selecting the proper pediatric dose: It is more than size that mattersG L Kearns
Current Opinion in Pediatrics|April 1, 1995
Pharmacogenetics and development: are infants and children at increased risk for adverse outcomes?G L Kearns
Inflammatory Bowel Diseases|August 1, 1998
Pharmacokinetics in infants and childrenG L Kearns
The Journal of Pediatrics|May 1, 1986
Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototypeG L Kearns, J M Trang
Clinical Pharmacokinetics|August 1, 1996
Pharmacokinetics and pharmacodynamics of famotidine in paediatric patientsL P James, G L Kearns
Clinical Pharmacology and Therapeutics|December 24, 2010
Histamine: new thoughts about a familiar mediatorB L Jones, G L Kearns
Clinical Pharmacology and Therapeutics|August 3, 1999
Developmental pharmacodynamics of cyclosporineJ D Marshall, G L Kearns
The Journal of the Arkansas Medical Society|September 1, 1984
Practical use of theophylline in children with asthmaT G Wells, G L Kearns
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Allergy and Clinical Immunology|September 13, 2000
Impact of developmental pharmacology on pediatric study design: overcoming the challengesG L Kearns
The Annals of Pharmacotherapy|January 1, 1993
Hepatic drug metabolism in cystic fibrosis: recent developments and future directionsG L Kearns
Clinical Pharmacology and Therapeutics|June 16, 2015
Selecting the proper pediatric dose: It is more than size that mattersG L Kearns
Current Opinion in Pediatrics|April 1, 1995
Pharmacogenetics and development: are infants and children at increased risk for adverse outcomes?G L Kearns
Inflammatory Bowel Diseases|August 1, 1998
Pharmacokinetics in infants and childrenG L Kearns
The Journal of Pediatrics|May 1, 1986
Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototypeG L Kearns, J M Trang
Clinical Pharmacokinetics|August 1, 1996
Pharmacokinetics and pharmacodynamics of famotidine in paediatric patientsL P James, G L Kearns
Clinical Pharmacology and Therapeutics|December 24, 2010
Histamine: new thoughts about a familiar mediatorB L Jones, G L Kearns
Clinical Pharmacology and Therapeutics|August 3, 1999
Developmental pharmacodynamics of cyclosporineJ D Marshall, G L Kearns
The Journal of the Arkansas Medical Society|September 1, 1984
Practical use of theophylline in children with asthmaT G Wells, G L Kearns
Pageof 18